STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Sees Significant Growth in Short Interest

STRATA Skin Sciences, Inc. (NASDAQ:SSKN) was the recipient of a large growth in short interest during the month of August. As of August 31st, there was short interest totalling 3,500 shares, a growth of 84.2% from the August 15th total of 1,900 shares. Approximately 0.1% of the shares of the company are short sold. Based on an average daily volume of 25,400 shares, the days-to-cover ratio is currently 0.1 days.

Insider Activity at STRATA Skin Sciences

In related news, CEO Dolev Rafaeli bought 19,100 shares of the company’s stock in a transaction on Monday, July 15th. The shares were bought at an average price of $3.14 per share, with a total value of $59,974.00. Following the transaction, the chief executive officer now owns 143,156 shares in the company, valued at $449,509.84. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CEO Dolev Rafaeli bought 19,100 shares of STRATA Skin Sciences stock in a transaction that occurred on Monday, July 15th. The stock was bought at an average price of $3.14 per share, for a total transaction of $59,974.00. Following the purchase, the chief executive officer now directly owns 143,156 shares of the company’s stock, valued at approximately $449,509.84. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Uri Geiger purchased 230,573 shares of the company’s stock in a transaction on Monday, July 15th. The shares were purchased at an average price of $3.14 per share, for a total transaction of $723,999.22. Following the purchase, the director now owns 1,441,835 shares in the company, valued at approximately $4,527,361.90. The disclosure for this purchase can be found here. 40.43% of the stock is currently owned by insiders.

Hedge Funds Weigh In On STRATA Skin Sciences

An institutional investor recently raised its position in STRATA Skin Sciences stock. Azzad Asset Management Inc. ADV boosted its stake in shares of STRATA Skin Sciences, Inc. (NASDAQ:SSKN) by 289.5% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 67,000 shares of the medical device company’s stock after acquiring an additional 49,800 shares during the quarter. Azzad Asset Management Inc. ADV owned 0.19% of STRATA Skin Sciences worth $25,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 32.43% of the company’s stock.

STRATA Skin Sciences Stock Performance

NASDAQ SSKN traded down $0.25 on Friday, hitting $3.01. 8,397 shares of the company’s stock traded hands, compared to its average volume of 11,780. The firm’s 50-day moving average price is $3.16 and its two-hundred day moving average price is $3.83. The firm has a market capitalization of $12.55 million, a PE ratio of -0.91 and a beta of 1.37. The company has a current ratio of 1.14, a quick ratio of 0.92 and a debt-to-equity ratio of 1.59. STRATA Skin Sciences has a 1-year low of $2.51 and a 1-year high of $10.00.

STRATA Skin Sciences (NASDAQ:SSKN) last issued its earnings results on Wednesday, August 14th. The medical device company reported ($0.03) earnings per share (EPS) for the quarter. STRATA Skin Sciences had a negative return on equity of 50.45% and a negative net margin of 25.40%. The business had revenue of $8.44 million for the quarter. As a group, analysts expect that STRATA Skin Sciences will post -1 EPS for the current year.

STRATA Skin Sciences Company Profile

STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.